![](/img/cover-not-exists.png)
Impact of ribociclib (RIB) dose reduction on overall survival (OS) in patients (pts) with HR+/HER2â advanced breast cancer (ABC) in MONALEESA (ML) -3 and -7
De Laurentiis, M., Merino, L. de la Cruz, Hart, L., Bardia, A., Im, S-A., Sohn, J., Neven, P., Martin, M., Ji, Y., Yang, S., Hu, H., Lteif, A., Tripathy, D.Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.433
Date:
September, 2020
File:
PDF, 101 KB
2020